PMA P210011S004

Device
xT CDx
Applicant
Tempus Labs, Inc.
PMA number
P210011
Supplement
S004
Product code
PQP
Decision date
2026-05-28
Classification
Pathology
Generic name
Next generation sequencing oncology panel, somatic or germline variant detection system
Approval order statement
Addition of an alternative method of germline subtraction and implementing an updated MSI caller in the bioinformatics pipeline.

Current openFDA PMA Record#

Device
xT CDx
Applicant
Tempus Labs, Inc.
PMA number
P210011
Supplement
S004
Product code
PQP
Generic name
Next generation sequencing oncology panel, somatic or germline variant detection system
Decision date
2026-05-28
Decision code
APPR
Date received
2025-06-30
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Approval order statement
Addition of an alternative method of germline subtraction and implementing an updated MSI caller in the bioinformatics pipeline.